From Name:
From Email:
To Name:
To Email:

Optional Message:

Tafamidis cuts deaths, admissions in TTR cardiac amyloidosis

from MedPage Today

Treatment with the investigational drug tafamidis was associated with a reduction in all-cause mortality and cardiovascular hospitalizations in patients with transthyretin (TTR) amyloid cardiomyopathy, and improved functional capacity and quality of life, the phase III ATTR-ACT trial found. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063